By studying and analyzing the patterns of the pathocomplex process, we came to the conclusion that multiple sclerosis, parkinsonism, and Alzheimer’s disease can also be assigned to systemic group of pathologies.

Based on the theory of the pathocomplex process, both multiple sclerosis, parkinsonism and Alzheimer’s disease emerge as a result of an extensive accumulation of pathocomplexes in the vascular system of the brain. The pathocomplex occlusion of the brain vessels immediately triggers scattered infarction of its tissues with subsequent necrosis and replacement of brain tissue with fibrous niduses, triggering a manifestation of symptoms particular to one disease or another, depending on the topographic characteristics of the lesions.

Whereas multiple schlerosis is not limited to a particular part of the brain, Parkinson's disease is known to affect primarily subcortical regions of the brain. 

Treatments of these pathologies based on the theory of the pathocomplex process demonstrate that symptoms of cerebral lesion become less pronounced with improved cerebral blood circulation, and in parallel, cerebral performance also increases, memory and intelligence functions recover. By eliminating the origin of systemic diseases, i.e. the pathocomplex process, the process of further blood vessel occlusion and hence, necrosis of cerebral tissues supplied by these blood vessels stops, thus suspending the spread of multiple sclerosis and progression of Parkinson’s and Alzheimer’s diseases. New niduses cease to form; however, unfortunately, previously formed niduses cannot be eliminated because they are now scars and so far, reconstructing a scar tissue back to a highly specific brain tissue is something that no one in the world can do. It is true that recently formed niduses can still recover once regenerated under the influence of the treatment process that aims to increase blood circulation. Also, once collateral circulation is improved, healthy regions of the brain can partially take over the functions of affected regions.

With improved blood circulation to the cortex and subcortical brain, the need for using drugs that are prescribed for treating the symptoms of Parkinson’s and Alzheimer’s diseases significantly reduces. At the same time, cyclic reactions that trigger trembling of the limbs become less frequent; memory and intelligence functionality improves.

As a result, we can stay that a treatment aimed at addressing the source of the diseases allows to significantly reduce disease intensity and to stop further spread of multiple sclerosis, parkinsonism, and Alzheimer’s disease and for early stages, even to completely eliminate them. Of course, if extensive connective tissue has already replaced specific tissues in the brain, then in this case, even our treatment cannot yield a substantial benefit, although, as noted earlier, it can stimulate healthy regions to take over the functions of affected regions. However, at the very least, elimination of the origin of these diseases fixates the state of the disease; the disease no longer processes and no longer aggravates by the formation of new lesions and this too, is an important outcome for such patients.